• Published On : Jan-2018 |
  • Pages : 170 Pages |
  • Format :

Table of Contents

1. Global Economic Outlook

2. Global Gynaecological Cancer Drugs Market - Executive Summary

3. Global Gynaecological Cancer Drugs Market Overview
     3.1. Introduction
            3.1.1. Global Gynaecological Cancer Drugs Market Taxonomy
            3.1.2. Global Gynaecological Cancer Drugs Market Definition
     3.2. Global Gynaecological Cancer Drugs Market Size (US$ Mn) and Forecast, 2012-2026
            3.2.1. Global Gynaecological Cancer Drugs Market Y-o-Y Growth
     3.3. Global Gynaecological Cancer Drugs Market Dynamics
     3.4. Supply Chain
     3.5. Cost Structure
     3.6. Cancer service provision by level of healthcare
     3.7. Gynaecological cancer drugs in pipeline
     3.8. Use of Nanomedicine for the treatment of Gynaecological Cancers
     3.9. Gynaecological Cancer Epidemiology
     3.10. Patent Analysis
     3.11. PESTL Analysis
     3.12. Product Lifecycle
     3.13. Service Provider List
     3.14. Key Participants Market Presence (Intensity Map) By Region

4. Global Gynaecological Cancer Drugs Market Analysis and Forecast 2012-2026 
     4.1. Global Gynaecological Cancer Drugs Market Size and Forecast By Drug Class, 2012-2026
            4.1.1. Alkylating Agent Market Size and Forecast, 2012-2026
                     4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.1.2. Market Share Comparison, By Region
                     4.1.1.3. Y-o-Y growth Comparison, By Region
            4.1.2. Plant Alkaloid Market Size and Forecast, 2012-2026
                     4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.2.2. Market Share Comparison, By Region
                     4.1.2.3. Y-o-Y growth Comparison, By Region
            4.1.3. Anthracyclines Market Size and Forecast, 2012-2026
                     4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.3.2. Market Share Comparison, By Region
                     4.1.3.3. Y-o-Y growth Comparison, By Region
            4.1.4. Antitumor Antibiotic Market Size and Forecast, 2012-2026
                     4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.4.2. Market Share Comparison, By Region
                     4.1.4.3. Y-o-Y growth Comparison, By Region
            4.1.5. Other Drug Class Market Size and Forecast, 2012-2026
                     4.1.5.1. Revenue (US$ Mn) Comparison, By Region
                     4.1.5.2. Market Share Comparison, By Region
                     4.1.5.3. Y-o-Y growth Comparison, By Region
     4.2. Global Gynaecological Cancer Drugs Market Size and Forecast By End User, 2012-2026
            4.2.1. Hospitals Market Size and Forecast, 2012-2026
                     4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.1.2. Market Share Comparison, By Region
                     4.2.1.3. Y-o-Y growth Comparison, By Region
            4.2.2. Clinics Market Size and Forecast, 2012-2026
                     4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.2.2. Market Share Comparison, By Region
                     4.2.2.3. Y-o-Y growth Comparison, By Region
            4.2.3. Specialized Cancer Treatment Centers Market Size and Forecast, 2012-2026
                     4.2.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.3.2. Market Share Comparison, By Region
                     4.2.3.3. Y-o-Y growth Comparison, By Region
            4.2.4. Other End Users Market Size and Forecast, 2012-2026
                     4.2.4.1. Revenue (US$ Mn) Comparison, By Region
                     4.2.4.2. Market Share Comparison, By Region
                     4.2.4.3. Y-o-Y growth Comparison, By Region
     4.3. Global Gynaecological Cancer Drugs Market Size and Forecast By Indication, 2012-2026
            4.3.1. Cervical Cancer Market Size and Forecast, 2012-2026
                     4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.1.2. Market Share Comparison, By Region
                     4.3.1.3. Y-o-Y growth Comparison, By Region
            4.3.2. Uterine Cancer Market Size and Forecast, 2012-2026
                     4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.2.2. Market Share Comparison, By Region
                     4.3.2.3. Y-o-Y growth Comparison, By Region
            4.3.3. Ovarian & Fallopian Tube Cancer Market Size and Forecast, 2012-2026
                     4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.3.2. Market Share Comparison, By Region
                     4.3.3.3. Y-o-Y growth Comparison, By Region
            4.3.4. Vulvar Cancer Market Size and Forecast, 2012-2026
                     4.3.4.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.4.2. Market Share Comparison, By Region
                     4.3.4.3. Y-o-Y growth Comparison, By Region
            4.3.5. Vaginal Cancer Market Size and Forecast, 2012-2026
                     4.3.5.1. Revenue (US$ Mn) Comparison, By Region
                     4.3.5.2. Market Share Comparison, By Region
                     4.3.5.3. Y-o-Y growth Comparison, By Region
     4.4. Global Gynaecological Cancer Drugs Market Size and Forecast By Distribution Channel, 2012-2026
            4.4.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
                     4.4.1.1. Revenue (US$ Mn) Comparison, By Region
                     4.4.1.2. Market Share Comparison, By Region
                     4.4.1.3. Y-o-Y growth Comparison, By Region
            4.4.2. Retail Pharmacies Market Size and Forecast, 2012-2026
                     4.4.2.1. Revenue (US$ Mn) Comparison, By Region
                     4.4.2.2. Market Share Comparison, By Region
                     4.4.2.3. Y-o-Y growth Comparison, By Region
            4.4.3. Market Size and Forecast, 2012-2026
                     4.4.3.1. Revenue (US$ Mn) Comparison, By Region
                     4.4.3.2. Market Share Comparison, By Region
                     4.4.3.3. Y-o-Y growth Comparison, By Region

5. North America Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026
     5.1. North America Outlook 
     5.2. North America Parent Market Outlook 
     5.3. North America Target Market Outlook 
     5.4. Revenue (US$ Mn) Comparison, By Country 
            5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
            5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
     5.5. Revenue (US$ Mn) Comparison, By Drug Class 
     5.6. Revenue (US$ Mn) Comparison, By End User 
     5.7. Revenue (US$ Mn) Comparison, By Indication 
     5.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. Latin America Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026
     6.1. Latin America Outlook 
     6.2. Latin America Parent Market Outlook 
     6.3. Latin America Target Market Outlook 
     6.4. Revenue (US$ Mn) Comparison, By Country 
            6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
            6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
            6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
     6.5. Revenue (US$ Mn) Comparison, By Drug Class 
     6.6. Revenue (US$ Mn) Comparison, By End User 
     6.7. Revenue (US$ Mn) Comparison, By Indication 
     6.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Europe Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026
     7.1. Europe Outlook 
     7.2. Europe Parent Market Outlook 
     7.3. Europe Target Market Outlook 
     7.4. Revenue (US$ Mn) Comparison, By Country 
            7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
            7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
            7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
            7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
            7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
            7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
     7.5. Revenue (US$ Mn) Comparison, By Drug Class 
     7.6. Revenue (US$ Mn) Comparison, By End User 
     7.7. Revenue (US$ Mn) Comparison, By Indication 
     7.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. Japan Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026
     8.1. Japan Outlook 
     8.2. Japan Parent Market Outlook 
     8.3. Japan Target Market Outlook 
     8.4. Revenue (US$ Mn) Comparison, 2012-2026 
            8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
     8.5. Revenue (US$ Mn) Comparison, By Drug Class 
     8.6. Revenue (US$ Mn) Comparison, By End User 
     8.7. Revenue (US$ Mn) Comparison, By Indication 
     8.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. APEJ Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026
     9.1. APEJ Outlook 
     9.2. APEJ Parent Market Outlook 
     9.3. APEJ Target Market Outlook 
     9.4. Revenue (US$ Mn) Comparison, By Country 
            9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
            9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
            9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
            9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
            9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
            9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
     9.5. Revenue (US$ Mn) Comparison, By Drug Class 
     9.6. Revenue (US$ Mn) Comparison, By End User 
     9.7. Revenue (US$ Mn) Comparison, By Indication 
     9.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. MEA Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026
     10.1. MEA Outlook 
     10.2. MEA Parent Market Outlook 
     10.3. MEA Target Market Outlook 
     10.4. Revenue (US$ Mn) Comparison, By Country 
            10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
            10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
            10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
            10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
     10.5. Revenue (US$ Mn) Comparison, By Drug Class 
     10.6. Revenue (US$ Mn) Comparison, By End User 
     10.7. Revenue (US$ Mn) Comparison, By Indication 
     10.8. Revenue (US$ Mn) Comparison, By Distribution Channel 

11. Global Gynaecological Cancer Drugs Market Company Share, Competition Landscape and Company Profiles
     11.1. Company Share Analysis
     11.2. Competition Landscape
     11.3. Company Profiles
            11.3.1. Roche Holdings AG
            11.3.2. AstraZeneca
            11.3.3. Sanofi
            11.3.4. Eli Lilly & Co.
            11.3.5. Pfizer Inc.
            11.3.6. Takeda Pharmaceuticals Co. Ltd.
            11.3.7. Bristol-Myers Squibb
            11.3.8. Merck & Co.
            11.3.9. Dr Reddy’s Laboratories
            11.3.10. Johnson & Johnson (Alza Corporation)
            11.3.11. GlaxoSmithKline (GSK)

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer


List of Tables

TABLE 1 Global Gynaecological Cancer Drugs Market Value (US$ Mn), 2012-2017
TABLE 2 Global Gynaecological Cancer Drugs Market Value (US$ Mn), 2018-2026
TABLE 3 Global Gynaecological Cancer Drugs Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Alkylating Agent Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Alkylating Agent Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Alkylating Agent Segment Market Share, By Region 2012-2017
TABLE 7 Global Alkylating Agent Segment Market Share, By Region 2018-2026
TABLE 8 Global Alkylating Agent Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Plant Alkaloid Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Plant Alkaloid Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Plant Alkaloid Segment Market Share, By Region 2012-2017
TABLE 12 Global Plant Alkaloid Segment Market Share, By Region 2018-2026
TABLE 13 Global Plant Alkaloid Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Anthracyclines Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Anthracyclines Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Anthracyclines Segment Market Share, By Region 2012-2017
TABLE 17 Global Anthracyclines Segment Market Share, By Region 2018-2026
TABLE 18 Global Anthracyclines Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Antitumor Antibiotic Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Antitumor Antibiotic Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Antitumor Antibiotic Segment Market Share, By Region 2012-2017
TABLE 22 Global Antitumor Antibiotic Segment Market Share, By Region 2018-2026
TABLE 23 Global Antitumor Antibiotic Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Other Drug Class Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Other Drug Class Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Other Drug Class Segment Market Share, By Region 2012-2017
TABLE 27 Global Other Drug Class Segment Market Share, By Region 2018-2026
TABLE 28 Global Other Drug Class Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Hospitals Segment Market Share, By Region 2012-2017
TABLE 32 Global Hospitals Segment Market Share, By Region 2018-2026
TABLE 33 Global Hospitals Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Clinics Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Clinics Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Clinics Segment Market Share, By Region 2012-2017
TABLE 37 Global Clinics Segment Market Share, By Region 2018-2026
TABLE 38 Global Clinics Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2012-2017
TABLE 42 Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2018-2026
TABLE 43 Global Specialized Cancer Treatment Centers Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Other End Users Segment Market Share, By Region 2012-2017
TABLE 47 Global Other End Users Segment Market Share, By Region 2018-2026
TABLE 48 Global Other End Users Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Cervical Cancer Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Cervical Cancer Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Cervical Cancer Segment Market Share, By Region 2012-2017
TABLE 52 Global Cervical Cancer Segment Market Share, By Region 2018-2026
TABLE 53 Global Cervical Cancer Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Uterine Cancer Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Uterine Cancer Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Uterine Cancer Segment Market Share, By Region 2012-2017
TABLE 57 Global Uterine Cancer Segment Market Share, By Region 2018-2026
TABLE 58 Global Uterine Cancer Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Ovarian & Fallopian Tube Cancer Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Ovarian & Fallopian Tube Cancer Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Ovarian & Fallopian Tube Cancer Segment Market Share, By Region 2012-2017
TABLE 62 Global Ovarian & Fallopian Tube Cancer Segment Market Share, By Region 2018-2026
TABLE 63 Global Ovarian & Fallopian Tube Cancer Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Vulvar Cancer Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Vulvar Cancer Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Vulvar Cancer Segment Market Share, By Region 2012-2017
TABLE 67 Global Vulvar Cancer Segment Market Share, By Region 2018-2026
TABLE 68 Global Vulvar Cancer Segment Y-o-Y, By Region 2017-2026
TABLE 69 Global Vaginal Cancer Segment Value (US$ Mn), By Region 2012-2017
TABLE 70 Global Vaginal Cancer Segment Value (US$ Mn), By Region 2018-2026
TABLE 71 Global Vaginal Cancer Segment Market Share, By Region 2012-2017
TABLE 72 Global Vaginal Cancer Segment Market Share, By Region 2018-2026
TABLE 73 Global Vaginal Cancer Segment Y-o-Y, By Region 2017-2026
TABLE 74 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 75 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 76 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 77 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 78 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 79 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 80 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 81 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 82 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 83 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 84 Global E-commerce Segment Value (US$ Mn), By Region 2012-2017
TABLE 85 Global E-commerce Segment Value (US$ Mn), By Region 2018-2026
TABLE 86 Global E-commerce Segment Market Share, By Region 2012-2017
TABLE 87 Global E-commerce Segment Market Share, By Region 2018-2026
TABLE 88 Global E-commerce Segment Y-o-Y, By Region 2017-2026
TABLE 89 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 90 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 91 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 92 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 93 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
TABLE 94 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
TABLE 95 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
TABLE 96 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
TABLE 97 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 98 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 99 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 100 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 101 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 102 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 103 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
TABLE 104 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
TABLE 105 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
TABLE 106 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
TABLE 107 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 108 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 109 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 110 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 111 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 112 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 113 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
TABLE 114 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
TABLE 115 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
TABLE 116 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
TABLE 117 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 118 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 119 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 120 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 121 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 122 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 123 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
TABLE 124 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
TABLE 125 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
TABLE 126 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
TABLE 127 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 128 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 129 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 130 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 131 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 132 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 133 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
TABLE 134 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
TABLE 135 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
TABLE 136 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
TABLE 137 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 138 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 139 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 140 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 141 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 142 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 143 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
TABLE 144 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
TABLE 145 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
TABLE 146 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
TABLE 147 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 148 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026


List of Figures

FIG. 1 Global Gynaecological Cancer Drugs Market Value (US$ Mn), 2012-2017
FIG. 2 Global Gynaecological Cancer Drugs Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Gynaecological Cancer Drugs Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Alkylating Agent Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Alkylating Agent Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Alkylating Agent Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Plant Alkaloid Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Plant Alkaloid Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Plant Alkaloid Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Anthracyclines Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Anthracyclines Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Anthracyclines Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Antitumor Antibiotic Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Antitumor Antibiotic Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Antitumor Antibiotic Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Other Drug Class Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Other Drug Class Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Other Drug Class Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Specialized Cancer Treatment Centers Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Cervical Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Cervical Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Cervical Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Uterine Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Uterine Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Uterine Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Ovarian & Fallopian Tube Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Ovarian & Fallopian Tube Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Ovarian & Fallopian Tube Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 Global Vulvar Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41 Global Vulvar Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42 Global Vulvar Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43 Global Vaginal Cancer Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 44 Global Vaginal Cancer Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 45 Global Vaginal Cancer Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 46 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 47 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 48 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 49 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 50 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 51 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 52 Global E-commerce Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 53 Global E-commerce Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 54 Global E-commerce Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 55 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 56 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 57 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 58 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 59 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
FIG. 60 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
FIG. 61 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
FIG. 62 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
FIG. 63 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 64 North America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 65 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 66 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 67 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 68 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 69 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
FIG. 70 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
FIG. 71 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
FIG. 72 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
FIG. 73 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 74 Latin America Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 75 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 76 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 77 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 78 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 79 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
FIG. 80 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
FIG. 81 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
FIG. 82 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
FIG. 83 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 84 Europe Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 85 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 86 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 87 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 88 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 89 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
FIG. 90 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
FIG. 91 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
FIG. 92 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
FIG. 93 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 94 Japan Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 95 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 96 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 97 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 98 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 99 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
FIG. 100 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
FIG. 101 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
FIG. 102 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
FIG. 103 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 104 APEJ Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 105 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 106 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 107 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 108 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 109 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2012-2017
FIG. 110 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By End Users 2018-2026
FIG. 111 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2012-2017
FIG. 112 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Indication 2018-2026
FIG. 113 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 114 MEA Gynaecological Cancer Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026